<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Middle East Afr J Ophthalmol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Middle East Afr J Ophthalmol</journal-id>
      <journal-id journal-id-type="publisher-id">MEAJO</journal-id>
      <journal-title-group>
        <journal-title>Middle East African Journal of Ophthalmology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0974-9233</issn>
      <issn pub-type="epub">0975-1599</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25100914</article-id>
      <article-id pub-id-type="pmc">4123282</article-id>
      <article-id pub-id-type="publisher-id">MEAJO-21-265</article-id>
      <article-id pub-id-type="doi">10.4103/0974-9233.134692</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Bilateral Choroidal Osteoma with Choroidal Neovascular Membrane Treated with Bevacizumab in a Child</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Agarwal</surname>
            <given-names>Manisha</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kantha</surname>
            <given-names>Meha</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mayor</surname>
            <given-names>Rahul</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Venkatesh</surname>
            <given-names>Ramesh</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shroff</surname>
            <given-names>Cyrus M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Department of Vitreoretina, Dr. Shroff's Charity Eye Hospital, Daryaganj, New Delhi, India</aff>
      <author-notes>
        <corresp id="cor1"><bold>Corresponding Author:</bold> Dr. Manisha Agarwal, Dr. Shroff's Charity Eye Hospital, 5027, Kedar Nath Road, Daryaganj - 110 002, New Delhi, India. E-mail: <email xlink:href="manisha@sceh.net">manisha@sceh.net</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jul-Sep</season>
        <year>2014</year>
      </pub-date>
      <volume>21</volume>
      <issue>3</issue>
      <fpage>265</fpage>
      <lpage>267</lpage>
      <permissions>
        <copyright-statement>Copyright: &#xA9; Middle East African Journal of Ophthalmology</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Choroidal osteoma is a rare benign tumor. We report a male child diagnosed with bilateral choroidal osteoma, high myopia and secondary choroidal neovascularization (CNV) membrane in one eye. Co-existence of posterior staphyloma made the clinical diagnosis of choroidal osteoma difficult due to the osteoma filling the depression of the posterior staphyloma. Typical findings on fundus fluorescein angiography, optical coherence tomography, B-scan and indocyanine green angiography confirmed the diagnosis. A review of literature was performed. CNV secondary to choroidal osteoma was treated with intravitreal bevacizumab and it responded well. Regular follow-up is essential for recurrence of CNV and decalcification of the osteoma.</p>
      </abstract>
      <kwd-group>
        <kwd>Bevacizumab</kwd>
        <kwd>Choroidal Neovascular Membrane</kwd>
        <kwd>Choroidal Osteoma</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="sec1-1">
      <title>INTRODUCTION</title>
      <p>Choroidal osteoma is a rare benign tumor. We report a male child diagnosed with bilateral choroidal osteoma, high myopia and secondary choroidal neovascularization (CNV) membrane in one eye. Co-existence of posterior staphyloma made the clinical diagnosis of choroidal osteoma difficult due to the osteoma filling the depression of the posterior staphyloma. On review of the literature we were unable to find a similar case of co-existant choroidal osteoma and posterior staphyloma reported earlier. CNV secondary to choroidal osteoma was treated with intravitreal bevacizumab. This case highlights the need for careful examination when presented with a case of choroidal osteoma filling the depression of a posterior staphyloma thereby making it appear flat rather than a typical elevated lesion.</p>
      <p>We report a case of bilateral choroidal osteoma-macular in the right eye and peripapillary with macular involvement in the left eye along with high myopia and posterior staphyloma in a male child associated with a CNV membrane in the left eye treated with the off-label use of intravitreal bevacizumab (Avastin; Genentech, San Francisco, CA, USA).</p>
    </sec>
    <sec id="sec1-2">
      <title>CASE REPORT</title>
      <p>A 10-year-old male patient presented with the complaints of decreased vision in the left eye for the last 4 days. On examination, the best corrected visual acuity (BCVA) in the right eye was 20/40, N6 and in the left eye 20/100, N9. Anterior segment examination was normal and the fundus examination of both eyes showed myopic discs with a posterior staphyloma and an extensive orangish-yellow flat lesion in the macular area of the right eye and in the peripapillary and macular area with submacular hemorrhage in the left eye [Figure <xref ref-type="fig" rid="F1">1a</xref> and <xref ref-type="fig" rid="F1">b</xref>].</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>(a) Color fundus photo of the right eye showing an orangish-yellow lesion in the macular area suggestive of a choroidal osteoma (b) Color fundus photo of the left eye showing the choroidal osteoma with submacular hemorrhage and choroidal neovascularization</p>
        </caption>
        <graphic xlink:href="MEAJO-21-265-g001"/>
      </fig>
      <p>Ultrasound B-Scan of both eyes showed a high reflective echo with shadowing at the posterior pole of both eyes. Patient underwent fundus fluorescein angiography (FFA) for both eyes which showed early hypofluorescence with late hyperfluorescence in the macular area of both eyes along with the peripapillary area in the left eye suggestive of the choroidal osteoma. There was an area of early hyperfluorescence which increased in size and intensity in the macular area of the left eye suggestive of an active CNV [<xref ref-type="fig" rid="F2">Figure 2a</xref>]. The indocyanine green angiography showed macular choroidal hypofluorescence in both eyes with an ill-defined hyperfluorescence plaque seen in the delayed frames of the left eye suggestive of a CNV [<xref ref-type="fig" rid="F2">Figure 2b</xref>]. Spectral domain optical coherence tomography of the left eye showed a steep curvature of the retinal layers due to posterior staphyloma along with a subfoveal CNV [<xref ref-type="fig" rid="F3">Figure 3</xref>].</p>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>(a) Fundus fluorescein angiography of the left eye showing an area of blocked fluorescence due to submacular hemorrhage and an area of hyperfluorescence within it suggestive of choroidal neovascularization (b) Indocyanine green angiography of the left eye showing macular choroidal hypofluorescence with an ill-defined hyperfluorescent plaque seen in the delayed frames of the left eye suggestive of a choroidal neovascularization</p>
        </caption>
        <graphic xlink:href="MEAJO-21-265-g002"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Optical coherence tomography of the left eye showing increased curvature of the retinal layers due to posterior staphyloma along with subfoveal choroidal neovascularization</p>
        </caption>
        <graphic xlink:href="MEAJO-21-265-g003"/>
      </fig>
      <p>He was diagnosed to have bilateral choroidal osteoma with an active subfoveal CNV in the left eye. He underwent a loading dose of three intravitreal injections of 1.25 mg/0.05 ml bevacizumab (off-label use) delivered to the inferotemporal quadrant of the left eye under strict aseptic precautions and short general anesthesia after an informed consent was signed by the parents.</p>
      <p>At 1 year follow-up after the last injection showed a BCVA of 20/60, N6 in the left eye. Fundus examination of the left eye showed choroidal osteoma in the macula with no evidence of submacular hemorrhage. FFA of the left eye showed staining of the CNV with no evidence of dye leakage.</p>
    </sec>
    <sec sec-type="discussion" id="sec1-3">
      <title>DISCUSSION</title>
      <p>Choroidal osteoma is a relatively rare benign intraocular tumor composed of mature bone that typically replaces the full thickness of the choroid. This tumor classically manifests as an orange-yellow plaque deep to the retina in the juxtapapillary or macular region.<xref rid="ref1" ref-type="bibr">1</xref> Nearly 80% are unilateral though Gass has described unilateral osteomas becoming bilateral.<xref rid="ref2" ref-type="bibr">2</xref> These tumors are said to show signs of evolution - growth of tumor, decalcification and CNV formation causing profound visual loss.</p>
      <p>Our patient has an osteoma involving the peripapillary and macular area, which is rare. We missed the diagnosis of the osteoma initially as the lesion appeared flat though the tumor is usually a little elevated. This was due to the tumor filling the depth of the co-existent posterior staphyloma. Based on our experience we recommend other clinicians to remain suspicious for a similar presentation when examining a myopic fundus with a posterior staphyloma. There was a large area of submacular hemorrhage overlying the osteoma, which may predispose to the formation of CNV along with an irregular surface of the tumor.<xref rid="ref3" ref-type="bibr">3</xref></p>
      <p>The possible reasons for the development of the CNV in these cases includes thin degenerated retinal pigment epithelium (RPE) overlying the osteoma allowing the growth of new blood vessels or an extension of the osteoma itself due to the presence of osteoclasts on histopathology.<xref rid="ref4" ref-type="bibr">4</xref></p>
      <p>The various treatments for CNV secondary to a choroidal osteoma include laser photocoagulation, photodynamic therapy (PDT), transpupillary thermotherapy (TTT) and surgical removal of the CNV. Laser photocoagulation especially for an extrafoveal CNV with osteoma, was found to be poorly responsive to laser photocoagulation due to depigmentation of the RPE and degenerated RPE/Bruch's membrane complex, resulting in the reduced uptake of laser energy.<xref rid="ref5" ref-type="bibr">5</xref> PDT requires multiple treatments and there is a risk of a drop in vision after the treatment.<xref rid="ref6" ref-type="bibr">6</xref> Visual results have been poor with TTT and surgical removal of the CNV associated with osteoma.<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref7" ref-type="bibr">7</xref>]</p>
      <p>In our case, the osteoma induced CNV was treated with a loading dose of three intravitreal bevacizumab injections (off label use) resulting in rapid regression of the CNV with a marked improvement in visual acuity. This treatment shows better visual recovery than the other treatments. Bevacizumab may have better penetration in these cases due to a very thinned and degenerated RPE/Bruch's membrane complex.<xref rid="ref8" ref-type="bibr">8</xref></p>
      <p>There are reports of CNV secondary to choroidal osteoma in adult patients treated with intravitreal bevacizumab.<xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref> However to the best of our knowledge this is the first report of a choroidal osteoma induced CNV treated with bevacizumab in a young child.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p><bold>Source of Support:</bold> Nil</p>
      </fn>
      <fn fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> None declared.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shields</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Shields</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Augsburger</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Choroidal osteoma</article-title>
          <source>Surv Ophthalmol</source>
          <year>1988</year>
          <volume>33</volume>
          <fpage>17</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="pmid">3051466</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gass</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>New observations concerning choroidal osteomas</article-title>
          <source>Int Ophthalmol</source>
          <year>1979</year>
          <volume>1</volume>
          <fpage>71</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">553048</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shields</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Demirci</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shields</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma</article-title>
          <source>Arch Ophthalmol</source>
          <year>2005</year>
          <volume>123</volume>
          <fpage>1658</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">16344436</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Foster</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Fernandez-Suntay</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Dryja</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Jakobiec</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>D'Amico</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Clinicopathologic reports, case reports, and small case series: Surgical removal and histopathologic findings of a subfoveal neovascular membrane associated with choroidal osteoma</article-title>
          <source>Arch Ophthalmol</source>
          <year>2003</year>
          <volume>121</volume>
          <fpage>273</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">12583798</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aylward</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Pautler</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Gass</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>A long-term follow-up of choroidal osteoma</article-title>
          <source>Arch Ophthalmol</source>
          <year>1998</year>
          <volume>116</volume>
          <fpage>1337</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="pmid">9790633</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Battaglia Parodi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Da Pozzo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Toto</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Saviano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ravalico</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Photodynamic therapy for choroidal neovascularization associated with choroidal osteoma</article-title>
          <source>Retina</source>
          <year>2001</year>
          <volume>21</volume>
          <fpage>660</fpage>
          <lpage>1</lpage>
          <pub-id pub-id-type="pmid">11756892</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharma</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sribhargava</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Shanmugam</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Choroidal neovascular membrane associated with choroidal osteoma (CO) treated with trans-pupillary thermo therapy</article-title>
          <source>Indian J Ophthalmol</source>
          <year>2004</year>
          <volume>52</volume>
          <fpage>329</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">15693329</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ahmadieh</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Vafi</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin)</article-title>
          <source>Graefes Arch Clin Exp Ophthalmol</source>
          <year>2007</year>
          <volume>245</volume>
          <fpage>1731</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="pmid">17653753</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Song</surname>
              <given-names>WK</given-names>
            </name>
            <name>
              <surname>Koh</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>OW</given-names>
            </name>
            <name>
              <surname>Byeon</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma</article-title>
          <source>Acta Ophthalmol</source>
          <year>2009</year>
          <volume>87</volume>
          <fpage>100</fpage>
          <lpage>1</lpage>
          <pub-id pub-id-type="pmid">19178391</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
